Delivery Order SPE2DR25D7066-SPE2DR26F7ZSU
- Not listed
- The Defense Logistics Agency awarded a $13,913.12 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL unit doses. The contract utilizes firm fixed price terms with a completion date of January 5, 2026, and represents a non-set-aside, competitively awarded transaction. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes, with a contract ceiling value of $36,199.94 and a completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical distributor supporting federal medical procurement needs,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 10 mg/ml in ampule form, with a contract ceiling value of $2,026.26 and an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order carries firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,913.80 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. The contract, awarded on January 5, 2026, with a completion date of January 6, 2026, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,132.07 under firm fixed price terms. The delivery order is not set-aside and represents a competitively awarded procurement. This award is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $15,833.10 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes. This is a firm fixed price delivery order with an ultimate completion date of December 16, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,454.71 on September 10, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed price, competitively awarded contract is a child order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a $3,214.86 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes in 0.5 ml quantities, with final delivery due by August 12, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $8,308.92 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on September 17, 2025, with completion targeted for September 18, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZSUDelivery Order
On January 6, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $9,685.88 to AmerSourceBergen Drug Corp for Phytonadione 1 mg/0.5 ml syringes. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by January 7, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables comprehensive pharmaceutical and medical supply deliveries to support military healthcare programs worldwide. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System and other government healthcare entities. The company's significant IDC with DLA encompasses a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for Phytonadione—a vitamin K supplement commonly used in military and veteran healthcare settings for coagulation management—exemplifies the routine but critical medical supply deliveries executed under the company's comprehensive federal contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 1/5/26 |